Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Other investigations, using the Hyp mouse as an animal model for the human disease X-linked hypophosphatemia (XLH), have demonstrated renal hypersensitivity to calcitonin (CT) using in vitro single renal tubule adenylate cyclase microassays. Renal hypersensitivity to CT may explain the elevated fractional excretion of phosphate (FE-P) and urinary 3'-5'-cyclic AMP (UcAMP) present in Hyp mice. This current study was designed as the in vivo counterpart to the in vitro experiments. CT dose-dependent hypocalcemia when data were constructed in normal and Hyp mice 18 hours after thyroparathyroidectomy (TPTX). Exogenous CT administered to TPTX normal mice resulted in dose-dependent hypocalcemia when data were expressed as the percent change from pretreatment. However, CT did not elicit a hypocalcemic response in TPTX Hyp mice at any dose. Only TPTX normal mice responded to CT with significant hypophosphatemia. FE-P and UcAMP were not significantly changed by CT in either genotype. In a different experiment, a large pharmacologic dose of CT was given to TPTX mice. This dose resulted in a significant but similar elevation of FE-P 1 hour after injection in both Hyp and normal TPTX mice. While UcAMP also rose significantly in both genotypes, the percent increase compared to controls was greater in Hyp mice. In summary, results from these in vivo experiments indicate that Hyp mice are not hypersensitive to physiologic doses of CT, and in fact they seem to be resistant to the hypocalcemic effect of the hormone. The greater increase in UcAMP in TPTX Hyp mice after a pharmacologic dose of CT may be the basis for the earlier in vitro results reported by others. We conclude that renal hypersensitivity to CT does not play a role in the etiology of XLH in the Hyp mouse.
Other investigations, using the Hyp mouse as an animal model for the human disease X-linked hypophosphatemia (XLH), have demonstrated renal hypersensitivity to calcitonin (CT) using in vitro single renal tubule adenylate cyclase microassays. Renal hypersensitivity to CT may explain the elevated fractional excretion of phosphate (FE-P) and urinary 3'-5'-cyclic AMP (UcAMP) present in Hyp mice. This current study was designed as the in vivo counterpart to the in vitro experiments. CT dose-dependent hypocalcemia when data were constructed in normal and Hyp mice 18 hours after thyroparathyroidectomy (TPTX). Exogenous CT administered to TPTX normal mice resulted in dose-dependent hypocalcemia when data were expressed as the percent change from pretreatment. However, CT did not elicit a hypocalcemic response in TPTX Hyp mice at any dose. Only TPTX normal mice responded to CT with significant hypophosphatemia. FE-P and UcAMP were not significantly changed by CT in either genotype. In a different experiment, a large pharmacologic dose of CT was given to TPTX mice. This dose resulted in a significant but similar elevation of FE-P 1 hour after injection in both Hyp and normal TPTX mice. While UcAMP also rose significantly in both genotypes, the percent increase compared to controls was greater in Hyp mice. In summary, results from these in vivo experiments indicate that Hyp mice are not hypersensitive to physiologic doses of CT, and in fact they seem to be resistant to the hypocalcemic effect of the hormone. The greater increase in UcAMP in TPTX Hyp mice after a pharmacologic dose of CT may be the basis for the earlier in vitro results reported by others. We conclude that renal hypersensitivity to CT does not play a role in the etiology of XLH in the Hyp mouse.
The sections in this article are: Chemical and Cellular Composition of Bone Extracellular Constituents of Bone Bone Cells Development and Structure of Bone Endochondral Ossification Intramembranous Ossification Skeletal Growth and Modeling Principles of Skeletal Growth Skeletal Modeling Epiphyseal Closure Bone Cell Function and Skeletal Growth and Modeling Bone Turnover and the Remodeling Cycle Skeletal Remodeling Cellular Control of Bone Remodeling Fracture Healing Bone Cell Function and Fracture Repair Interrelationships of Kidney and Bone in Normal Physiology General Considerations Overall Calcium Balance Hormonal Control of Mineral Ion Homeostasis Role of the Parathyroid Glands in the Calcium Homeostatic System Bone Cell Function and Ionic Homeostasis Aspects of Renal Function Essential for Normal Skeletal Structure and Function and Ionic Homeostasis Metabolic Bone Disease Osteitis Fibrosa Osteomalacia Osteoporosis Laboratory Evaluation of Metabolic Bone Disease Direct Assays of Calcium‐Regulating Hormones in Blood Clinical Assessment of the Function of Target Organs for Calcium‐Regulating Hormones Abnormalities in Renal Function Leading to Skeletal Disease Abnormalities in Renal Calcium Handling Abnormalities in Renal Phosphate Handling Hypo‐ and Hypermagnesemia Due to Renal Causes Renal Tubular Acidosis Primary Abnormalities in Vitamin D Metabolism Renal Resistance to PTH : Pseudohypoparathyroidism Chronic Renal Insufficiency Pathophysiology of Renal Osteodystrophy Disorders Affecting the Homeostatic Mechanisms Linking Kidney and Bone Primary Hyperparathyroidism Humoral Hypercalcemia of Malignancy Hypoparathyroidism Deficient Quantities and Action of Vitamin D Hypervitaminosis D Sarcoidosis and Other Granulomatous Diseases Other Hormonal Abnormalities and Drugs Affecting Both Bone and Kidney Calcitonin Growth Hormone Estrogen Glucocorticoids Insulin Thyroid Hormones Miscellaneous Associations Between Bone and Kidney Disorders Affecting Both Kidney and Bone Pharmacological Agents Affecting Both Kidney and Bone Effects of Bone Disease on the Kidney
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.